Page last updated: 2024-11-04

temozolomide and Fatty Liver

temozolomide has been researched along with Fatty Liver in 1 studies

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miller, RJ1
Gui, X1
Easaw, JC1
Tsang, RY1

Other Studies

1 other study available for temozolomide and Fatty Liver

ArticleYear
Chemotherapy-associated steatohepatitis with temozolomide and dexamethasone.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2012, Volume: 39, Issue:4

    Topics: Antineoplastic Agents; Dacarbazine; Dexamethasone; Diabetes Mellitus, Type 2; Fatty Liver; Glioblast

2012